What does PepGen Inc. do?
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment…
What is PepGen Inc.'s P/E and P/B ratio?
PepGen Inc. has a P/E ratio of -2.7 and a P/B ratio of 1.56.
What is PepGen Inc.'s debt-to-equity ratio?
PepGen Inc. has a debt-to-equity ratio of 0.13.
How much does PepGen Inc. owe compared with what it owns?
PepGen Inc. owes $0.15 for every $1 it owns (balance sheet Jun 2026), which is low.
What is PepGen Inc.'s Positivity rank?
PepGen Inc. is ranked #2,652 of 6,775 companies globally and #883 of 3,999 in United States on PositoAI, with a Positivity Score of 21,360.
Does PepGen Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for PepGen Inc..
Where can I read the latest news about PepGen Inc.?
Recent headlines about PepGen Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does PepGen Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of PepGen Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.